← Back to Search

Treatment for Alzheimer's Disease (TRC-PAD Trial)

N/A
Waitlist Available
Led By Reisa Sperling, MD
Research Sponsored by University of Southern California
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights

Summary

This trial is to develop a group of people who are likely to get Alzheimer's disease and who are willing to be in future trials testing ways to prevent it.

Eligible Conditions
  • Alzheimer's Disease
  • Dementia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Optimization of adaptive risk algorithm to predict risk of amyloid positivity

Find a Location

Who is running the clinical trial?

Alzheimer's Clinical Trials ConsortiumOTHER
4 Previous Clinical Trials
2,540 Total Patients Enrolled
Alzheimer's Therapeutic Research InstituteOTHER
17 Previous Clinical Trials
58,005 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,733 Previous Clinical Trials
28,054,783 Total Patients Enrolled
~35 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top